ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 350 filers reported holding ARGENX SE in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,477,187 | +8.1% | 3,435 | -1.1% | 1.52% | +10.5% |
| Q1 2024 | $1,366,996 | +3.4% | 3,472 | -0.1% | 1.38% | -5.7% |
| Q4 2023 | $1,321,614 | -20.8% | 3,474 | +2.4% | 1.46% | -32.2% |
| Q3 2023 | $1,668,101 | +12.0% | 3,393 | -11.2% | 2.15% | +20.0% |
| Q2 2023 | $1,489,158 | +5.0% | 3,821 | +0.4% | 1.79% | -8.7% |
| Q1 2023 | $1,417,667 | -51.5% | 3,805 | -50.7% | 1.96% | -30.1% |
| Q4 2022 | $2,924,189 | +12.9% | 7,719 | +5.2% | 2.81% | +12.7% |
| Q3 2022 | $2,591,000 | -10.3% | 7,338 | -3.8% | 2.49% | -20.8% |
| Q2 2022 | $2,890,000 | -34.2% | 7,628 | -45.2% | 3.15% | +3.1% |
| Q1 2022 | $4,391,000 | -48.2% | 13,925 | -42.4% | 3.05% | -25.0% |
| Q4 2021 | $8,473,000 | +82.1% | 24,196 | +57.0% | 4.07% | +97.0% |
| Q3 2021 | $4,654,000 | +23.0% | 15,410 | +22.7% | 2.06% | +18.3% |
| Q2 2021 | $3,783,000 | +25.8% | 12,564 | +15.1% | 1.74% | -1.8% |
| Q1 2021 | $3,006,000 | +16.2% | 10,917 | +24.1% | 1.78% | -9.9% |
| Q4 2020 | $2,587,000 | – | 8,798 | – | 1.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |